Cancer vaccine (Cosmo Pharmaceuticals)

N/A

Report date: 2022/07/19 16:22:54

Base Information

Drug NameCancer vaccine (Cosmo Pharmaceuticals)
Drug Alias Name癌症疫苗 - 科斯莫制药集团肿瘤疫苗 - 科斯莫制药集团TLICB-1001CB-10-01
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulantsTelomerase inhibitors
TargetsTelomerase
Therapy Area/IndicationsSkin MelanomaHematologic NeoplasmsLymphoma, Non-Hodgkin +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCosmo Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesStanford UniversityCosmo Bioscience Spa
Active IndicationsN/A
Inactive IndicationsSkin MelanomaHematologic NeoplasmsLymphoma, Non-Hodgkin +[4] 

Other Information

ATC CodeN/A
Related LinksN/A